bisantrene has been researched along with elliptinium in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Capranico, G; Mabilia, M; Palumbo, M; Pozzan, A; Tinelli, S; Zunino, F | 1 |
| Denny, WA; Feigon, J; Kearns, DR; Leupin, W | 1 |
2 other study(ies) available for bisantrene and elliptinium
| Article | Year |
|---|---|
Conformational drug determinants of the sequence specificity of drug-stimulated topoisomerase II DNA cleavage.
Topics: Anthracenes; Anthraquinones; Antineoplastic Agents; Computer Graphics; DNA; DNA Topoisomerases, Type II; Electrophoresis, Polyacrylamide Gel; Ellipticines; Genistein; Intercalating Agents; Isoflavones; Models, Molecular; Molecular Conformation; Pyrazoles; Receptors, Drug; Structure-Activity Relationship; Substrate Specificity | 1994 |
Interactions of antitumor drugs with natural DNA: 1H NMR study of binding mode and kinetics.
Topics: Antineoplastic Agents; Base Composition; Chemical Phenomena; Chemistry; DNA; Hydrogen Bonding; Intercalating Agents; Kinetics; Magnetic Resonance Spectroscopy; Structure-Activity Relationship | 1984 |